| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Juan Pérez-Fernández, Marcus Stephenson-Jones, Shreyas M Suryanarayana, Brita Robertson, Sten Grillne. Evolutionarily conserved organization of the dopaminergic system in lamprey: SNc/VTA afferent and efferent connectivity and D2 receptor expression. The Journal of comparative neurology. vol 522. issue 17. 2015-05-19. PMID:24942187. |
the dopaminergic system influences motor behavior, signals reward and novelty, and is an essential component of the basal ganglia in all vertebrates including the lamprey, one of the phylogenetically oldest vertebrates. |
2015-05-19 |
2023-08-13 |
Not clear |
| Peter Jenne. Treatment of the later stages of Parkinson's disease - pharmacological approaches now and in the future. Translational neurodegeneration. vol 4. 2015-05-14. PMID:25973178. |
new pharmacological options are expanding with the advent of longer acting versions of existing dopaminergic drugs, new drug delivery systems and the introduction of non-dopaminergic agents able to manipulate motor function both within the basal ganglia and in other brain regions. |
2015-05-14 |
2023-08-13 |
Not clear |
| Nobuhito Nakajima, Masayuki Ueda, Hiroshi Nagayama, Yasuo Katayam. Putaminal changes before the onset of clinical symptoms in diabetic hemichorea-hemiballism. Internal medicine (Tokyo, Japan). vol 53. issue 5. 2015-05-12. PMID:24583441. |
pronounced potential basal ganglia impairment under hyperglycemia and central dopaminergic hyperactivity was important for the development of dhc-hb in this patient. |
2015-05-12 |
2023-08-12 |
Not clear |
| Jivago Röpke, Alcindo Busanello, Caroline Queiroz Leal, Elizete de Moraes Reis, Catiuscia Molz de Freitas, Jardel Gomes Villarinho, Fernanda Hernandes Figueira, Carlos Fernando Mello, Juliano Ferreira, Roselei Fachinett. Anandamide attenuates haloperidol-induced vacuous chewing movements in rats. Progress in neuro-psychopharmacology & biological psychiatry. vol 54. 2015-05-12. PMID:24747871. |
although the dopaminergic system has been implicated in these movement disorders, which involve the basal ganglia, their underlying pathomechanisms remain unclear. |
2015-05-12 |
2023-08-13 |
rat |
| Nicolas Morin, Thérèse Di Paol. Interaction of adenosine receptors with other receptors from therapeutic perspective in Parkinson's disease. International review of neurobiology. vol 119. 2015-05-12. PMID:25175965. |
altered dopaminergic neurotransmission in the basal ganglia is observed in parkinson's disease (pd) and l-3,4-dihydroxyphenylalanine (l-dopa)-induced dyskinesias (lid). |
2015-05-12 |
2023-08-13 |
Not clear |
| Madeleine W Cunningha. Rheumatic fever, autoimmunity, and molecular mimicry: the streptococcal connection. International reviews of immunology. vol 33. issue 4. 2015-04-16. PMID:24892819. |
in sydenham chorea, human mabs and their expression in transgenic mice have linked autoimmunity to central dopamine pathways as well as dopamine receptors and dopaminergic neurons in basal ganglia. |
2015-04-16 |
2023-08-13 |
mouse |
| Anu G Nair, Omar Gutierrez-Arenas, Olivia Eriksson, Alexandra Jauhiainen, Kim T Blackwell, Jeanette H Kotalesk. Modeling intracellular signaling underlying striatal function in health and disease. Progress in molecular biology and translational science. vol 123. 2015-04-02. PMID:24560149. |
striatum, which is the input nucleus of the basal ganglia, integrates cortical and thalamic glutamatergic inputs with dopaminergic afferents from the substantia nigra pars compacta. |
2015-04-02 |
2023-08-12 |
Not clear |
| Sunghyon Kyeong, Eunjoo Kim, Hae-Jeong Park, Dong-Uk Hwan. Functional network organizations of two contrasting temperament groups in dimensions of novelty seeking and harm avoidance. Brain research. vol 1575. 2015-03-30. PMID:24881884. |
in the 'low ha and high ns' group, however, brain regions lying on the dopaminergic pathways, such as the pfc and basal ganglia, are partitioned together. |
2015-03-30 |
2023-08-13 |
human |
| Jennifer T Coul. Getting the timing right: experimental protocols for investigating time with functional neuroimaging and psychopharmacology. Advances in experimental medicine and biology. vol 829. 2015-03-26. PMID:25358714. |
in our own studies, we have found that estimating event duration, whether that estimate is provided by a motor response or a perceptual discrimination, typically recruits basal ganglia, sma and right inferior frontal cortex, and can be modulated by dopaminergic activity in these areas. |
2015-03-26 |
2023-08-13 |
human |
| Elodie Durand, Odile Petit, Léon Tremblay, Cédric Zimmer, Véronique Sgambato-Faure, Carine Chassain, Marlène Laurent, Bruno Pereira, Céline Silberberg, Franck Duri. Social behavioral changes in MPTP-treated monkey model of Parkinson's disease. Frontiers in behavioral neuroscience. vol 9. 2015-03-13. PMID:25767440. |
dopaminergic denervation within basal ganglia and cortical areas was evaluated using positron emission tomography (pet) scans with (18)f-dopa (6-[18f]-fluoro-l-3,4-dihydroxyphenylalanine) radiotracer. |
2015-03-13 |
2023-08-13 |
monkey |
| Simon Little, Huiling Tan, Anam Anzak, Alek Pogosyan, Andrea Kühn, Peter Brow. Bilateral functional connectivity of the basal ganglia in patients with Parkinson's disease and its modulation by dopaminergic treatment. PloS one. vol 8. issue 12. 2015-03-03. PMID:24376574. |
bilateral functional connectivity of the basal ganglia in patients with parkinson's disease and its modulation by dopaminergic treatment. |
2015-03-03 |
2023-08-12 |
human |
| Morvarid Karimi, Joel S Perlmutte. The role of dopamine and dopaminergic pathways in dystonia: insights from neuroimaging. Tremor and other hyperkinetic movements (New York, N.Y.). vol 5. 2015-02-25. PMID:25713747. |
overwhelming data suggest involvement of basal ganglia and dopaminergic pathways in dystonia. |
2015-02-25 |
2023-08-13 |
Not clear |
| Adriana Galvan, Annaelle Devergnas, Thomas Wichman. Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state. Frontiers in neuroanatomy. vol 9. 2015-02-20. PMID:25698937. |
most of the mentioned electrophysiologic changes are probably related to the degeneration of diencephalic dopaminergic neurons, leading to dopamine loss in the striatum and other basal ganglia nuclei, although degeneration of non-dopaminergic cell groups may also have a role. |
2015-02-20 |
2023-08-13 |
Not clear |
| Robert B Laprairie, Amina M Bagher, Sophie V Precious, Eileen M Denovan-Wrigh. Components of the endocannabinoid and dopamine systems are dysregulated in Huntington's disease: analysis of publicly available microarray datasets. Pharmacology research & perspectives. vol 3. issue 1. 2015-02-18. PMID:25692022. |
the endocannabinoid system (ecs) and the dopaminergic system (das) are two major regulators of basal ganglia function. |
2015-02-18 |
2023-08-13 |
human |
| Lindsey G McIntosh, Sishir Mannava, Corrie R Camalier, Bradley S Folley, Aaron Albritton, Peter E Konrad, David Charles, Sohee Park, Joseph S Neima. Emotion recognition in early Parkinson's disease patients undergoing deep brain stimulation or dopaminergic therapy: a comparison to healthy participants. Frontiers in aging neuroscience. vol 6. 2015-02-05. PMID:25653616. |
parkinson's disease (pd) is traditionally regarded as a neurodegenerative movement disorder, however, nigrostriatal dopaminergic degeneration is also thought to disrupt non-motor loops connecting basal ganglia to areas in frontal cortex involved in cognition and emotion processing. |
2015-02-05 |
2023-08-13 |
human |
| E A Pelzer, A Hintzen, L Timmermann, M Tittgemeye. [Satellite systems of the basal ganglia--anatomic position, clinical relevance]. Fortschritte der Neurologie-Psychiatrie. vol 82. issue 6. 2015-01-26. PMID:24901315. |
the investigation of these satellite systems would be invaluable to foster our understanding of basal ganglia circuitries and may yield a better appreciation of largely opaque symptoms like resting tremor in parkinson's disease; analysis of these anatomic pathways and functional implications may facilitate explanatory model approaches to side effects due to dopaminergic therapy and deep brain stimulation in humans and thereby offer the possibility for new therapeutic approaches in movement disorders. |
2015-01-26 |
2023-08-13 |
Not clear |
| Damian M Herz, Simon B Eickhoff, Annemette Løkkegaard, Hartwig R Siebne. Functional neuroimaging of motor control in Parkinson's disease: a meta-analysis. Human brain mapping. vol 35. issue 7. 2015-01-22. PMID:24123553. |
in the basal ganglia, pd patients expressed a decrease of motor activation in the posterior motor putamen, which improved with dopaminergic medication. |
2015-01-22 |
2023-08-12 |
Not clear |
| Shinichi Amano, Deborah Kegelmeyer, S Lee Hon. Rethinking energy in parkinsonian motor symptoms: a potential role for neural metabolic deficits. Frontiers in systems neuroscience. vol 8. 2015-01-22. PMID:25610377. |
research spanning several decades has emphasized basal ganglia dysfunction, predominantly resulting from dopaminergic (da) cell loss, as the primarily cause of the aforementioned parkinsonian features. |
2015-01-22 |
2023-08-13 |
Not clear |
| Mona Leblond, Tatyana Sukharnikova, Chunxiu Yu, Mark A Rossi, Henry H Yi. The role of pedunculopontine nucleus in choice behavior under risk. The European journal of neuroscience. vol 39. issue 10. 2015-01-06. PMID:24617747. |
the dopaminergic projections to the basal ganglia have long been implicated in reward-guided behavior and decision-making, yet little is known about the role of the posterior pedunculopontine nucleus (pppn), a major source of excitatory input to the mesolimbic dopamine system. |
2015-01-06 |
2023-08-12 |
rat |
| M R Williams, K Galvin, B O'Sullivan, C D MacDonald, E W K Ching, F Turkheimer, O D Howes, R K B Pearce, S R Hirsch, M Maie. Neuropathological changes in the substantia nigra in schizophrenia but not depression. European archives of psychiatry and clinical neuroscience. vol 264. issue 4. 2015-01-05. PMID:24374935. |
the substantia nigra is a basal ganglia nucleus responsible for the production of dopamine and projection of dopaminergic neurons to the striatum. |
2015-01-05 |
2023-08-12 |
Not clear |